Compounds > magnesium-pyridoxal-5'-phosphate glutamate
Page last updated: 2024-09-05

magnesium-pyridoxal-5'-phosphate glutamate and Hyperlipoproteinemia Type II

magnesium-pyridoxal-5'-phosphate glutamate has been researched along with Hyperlipoproteinemia Type II in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kastelein, JJ; Kindt, I; Knipscheer, HC; Mulder, WJ; Nurmohamed, MT; Smalbraak, H; van den Ende, A1

Trials

1 trial(s) available for magnesium-pyridoxal-5'-phosphate glutamate and Hyperlipoproteinemia Type II

ArticleYear
Magnesium pyridoxal-5'-phosphate glutamate, "A vitamin B6 derivative", does not affect lipoprotein levels in patients with familial hypercholesterolaemia.
    European journal of clinical pharmacology, 1997, Volume: 51, Issue:6

    Topics: Adult; Anticholesteremic Agents; Double-Blind Method; Female; Glutamine; Humans; Hyperlipoproteinemia Type II; Lipoproteins; Male; Pyridoxal Phosphate

1997